Back to company

PROXEON BIOSYSTEMS ApS: Financial statements 2018

CVR: 26848024

PROXEON BIOSYSTEMS ApS (CVR 26848024) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 47,689,000 and a net result of DKK 36,246,000 compared with DKK 29,486,000 the year before. That is an increase of 25.6% compared with the year before. Equity amounted to DKK 285,053,000. The solvency ratio was 96.3%.

Gross Profit
47,689,000 kr.
Profit/Loss
36,246,000 kr.
Equity
285,053,000 kr.
Total Assets
295,865,000 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-47.7 mio.36.2 mio.285.1 mio.-
2017-38 mio.29.5 mio.248.8 mio.-
2016-39.9 mio.31.1 mio.219.3 mio.-
2015-64 mio.50.1 mio.188.2 mio.-
2014-58.4 mio.45.5 mio.138.1 mio.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on PROXEON BIOSYSTEMS ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

PROXEON BIOSYSTEMS ApS: The 2017 annual report is outJun 8, 2018

PROXEON BIOSYSTEMS ApS has published its annual report for 2017. Gross profit came to DKK 37,968,000, and the net result was DKK 29,486,000.

About PROXEON BIOSYSTEMS ApS

PROXEON BIOSYSTEMS ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Lie. The company is owned by NUNC A/S. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 2,950,000 compared with DKK 3,703,000 the year before. Equity amounted to DKK 386,590,000.